Nils behrendt biography
•
BII alumnus Adcendo raises EUR 51 million
Adcendo, a spinout from The Finsen Laboratory, The University of Copenhagen and Rigshospitalet, and BioInnovation Institute (BII) alumnus, has raised EUR 51M in a series A financing led by Novo Seeds and Ysios Capital, along with RA Capital Management, HealthCap and Gilde Healthcare.
It is one of the largest series A investments in the history of Danish biotech.
The company is developing antibody-drug conjugates (ADCs) for the treatment of cancers focusing on soft-tissue sarcoma (STS), a cancer type occurring in many places in the body. The financing will be used to establish a pipeline of ADCs directed at novel cancer targets and to bring the lead program focusing on the main target uPARAP/Endo180 to proof of concept in patients.
In 2019, the company was accepted in the Creation House program and had already delivered an early proof of concept demonstrating a 100 percent cure rate of their cancer-bearing mice in the initial in vivo stud
•
Spin-out from Rigshospitalet funded with DKK 10M
BioInnovation Institute welcomes ADCendo to the Creation House program. During the coming 18 months, the company will continue their work to develop a treatment for mainly soft-tissue sarcoma (STS), a cancer type occurring many places in the body, as well as other cancers, including glioblastomas which are found in the brain.
“In the western world alone, STS affect around 40.000 people every year and are primarily treated with surgery. However, if there are metastases there is currently no efficient treatment for the patients. An even higher number of patients suffer from the other cancer types such as glioblastomas. In ADCendo we are building on decades of basic research from Rigshospitalet to develop a targeted treatment based on antibody-drug conjugates against a specific cellular receptor on these cancers”, says Niels Behrendt, co-founder and CSO.
The company was founded in 2017 by CSO Niels Behrendt, CTO Christoffer Nielsen, C
•
Karen Blixen
Danish writer (1885–1962)
Karen Blixen | |
|---|---|
Blixen in 1957 | |
| Born | Karen Christenze Dinesen 17 April 1885 Rungsted, Zealand, Denmark |
| Died | 7 September 1962(1962-09-07) (aged 77) Rungsted, Zealand, Denmark |
| Pen name | Isak Dinesen, Tania Blixen |
| Occupation | Writer |
| Language | English, Danish |
| Notable works | Out of Africa, Seven Gothic Tales, Shadows on the Grass, Babette's Feast |
| Spouse | |
| Partner | Denys Finch Hatton |
| Relatives | Ellen Dahl (sister) Thomas Dinesen (brother) Andreas Nicolai Hansen (great-grandfather) Mary Westenholz (aunt) |
Baroness Karen Christenze von Blixen-Finecke (born Dinesen; 17 April 1885 – 7 September 1962) was a Danish author who wrote in Danish and English. She is also known beneath her pen namesIsak Dinesen, used in English-speaking countries; Tania Blixen, used in German-speaking countries; Osceola, and Pierre Andrézel.
Blixen fryst vatten best known for Out of Africa, an konto of her life whil